市場調査レポート
商品コード
1309756

イムノアッセイ市場:戦略と動向、用途別、技術別、製品別、ユーザー別、国別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)

IMMUNOASSAY MARKETS. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive and Consultant Guides. 2023 to 2027

出版日: | 発行: Howe Sound Research | ページ情報: 英文 416 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
イムノアッセイ市場:戦略と動向、用途別、技術別、製品別、ユーザー別、国別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)
出版日: 2023年07月06日
発行: Howe Sound Research
ページ情報: 英文 416 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のイムノアッセイ市場について調査し、市場の概要とともに、用途別、技術別、製品別、ユーザー別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 業界の概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関
  • 臨床検査市場セグメント
  • イムノアッセイ- 市場とディスカッション

第4章 市場動向

  • 成長促進要因
  • 成長抑制要因
  • イムノアッセイ装置

第5章 イムノアッセイの最近の発展

第6章 主要企業プロファイル

  • Abbott Laboratories
  • Abcam
  • Abionic
  • Accel Diagnostics
  • Applied BioCode
  • Arlington Scientific
  • Arrayit Corporation
  • Atomo Diagnostics
  • Aureum Diagnostics
  • Aurora Biomed
  • Autobio Diagnostics
  • AVIVA Systems Biology
  • Awareness Technology
  • Axis-Shield Diagnostics Ltd.
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Biocartis
  • Biomatik
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • Boditech Med, Inc
  • Boster Biological Technology
  • Diamedix(Erba Diagnostics)
  • Diasorin S.p.A.
  • Dynex Technologies
  • Enzo Biochem
  • Eurofins Scientific
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Gold Standard Diagnostics
  • Grifols
  • Hycor Biomedical
  • Immunodiagnostic Systems(IDS)
  • Immunodiagnostik AG
  • Inova Diagnostics
  • JR Biomedical
  • Luminex Corp
  • Maxim Biomedical
  • Mbio Diagnostics
  • Meso Scale Discovery
  • Millipore Sigma
  • Mindray
  • Molecular Devices
  • MP Biomedical
  • Operon
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Qiagen
  • Quidel
  • R&D Systems
  • Randox Toxicology
  • Roche Molecular Diagnostics
  • SD Biosensor
  • Siemens Healthineers
  • Sysmex
  • Tecan
  • Thermo Fisher Scientific Inc.
  • TOSOH Bioscience
  • Veredus Laboratories
  • Vircell
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第7章 世界市場

  • 国別の世界市場
  • 用途別の世界市場
  • 技術別の世界市場
  • 製品別の世界市場
  • ユーザー別の世界市場

第8章 世界市場、用途別

  • 内分泌学
  • 免疫
  • 腫瘍学
  • 感染症
  • 心臓病学
  • その他

第9章 世界市場、技術別

  • 酵素
  • 蛍光性
  • 化学発光
  • 核酸
  • 迅速/POC
  • その他

第10章 世界市場、製品別

  • 装置
  • 試薬
  • サービス

第11章 世界市場、ユーザー別

  • 病院
  • 外来検査室
  • POC/その他

第12章 イムノアッセイの将来のビジョン

第13章 付録

図表

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Clinical Laboratory Departments and Segments
  • Table 3 Laboratory Management Focus - Different Approaches
  • Table 4 Key Segmentation Variables Going Forward
  • Table 5 The Different Markets for Immunoassay
  • Table 6 The Factors Driving Growth
  • Table 7 Factors Limiting Growth
  • Table 8 - Listing of Instrument Specifications
  • Table 9 The Global Immunoassay Market by Country
  • Table 10 Global Market by Application
  • Table 11 Global Market by Technology
  • Table 12 Global Market by Product
  • Table 13 Global Market by User
  • Table 14 Endocrinology Immunoassay by Country
  • Table 15 Immune Immunoassay by Country
  • Table 16 Oncology Immunoassay by Country
  • Table 17 Infectious Disease Immunoassay by Country
  • Table 18 Cardiology Immunoassay by Country
  • Table 19 Other Immunoassay by Country
  • Table 20 Enzyme Immunoassay by Country
  • Table 21 Flourescence Immunoassay by Country
  • Table 22 Chemiluminescence Immunoassay by Country
  • Table 23 Nucleic Acid Immunoassay by Country
  • Table 24 Rapid/POC Immunoassay by Country
  • Table 25 Other Technology Immunoassay by Country
  • Table 26 Instrument by Country
  • Table 27 Reagents by Country
  • Table 28 Services by Country
  • Table 29 Hospital Usrr by Country
  • Table 30 Outpatient Lab by Country
  • Table 31 POC/Other by Country
  • Table 32 Clinical Lab Fee Schedule
  • Table 33 The Most Common Assays
  • Table 34 Largest Revenue Assays

Table of Figures

  • Figure 1 Global Healthcare Spending
  • Figure 2 The Lab Test Pie
  • Figure 3 The Road to Diagnostics
  • Figure 4 Immunoassay - Country Sharea
  • Figure 5 Chart of Growth by Application
  • Figure 6 Chart of Segment by Year
  • Figure 7 Chart of Base vs. Final
  • Figure 8 Chart of Base Year by Application
  • Figure 9 Chart of Final Year by Application
  • Figure 10 Chart of Growth by Technology
  • Figure 11 Chart of Technology Segment by Year
  • Figure 12 Chart of Technology Base vs. Final
  • Figure 13 Chart of Base Year by Technology
  • Figure 14 Chart of Final Year by Technology
  • Figure 15 Chart of Growth by Product
  • Figure 16 Chart of Product Segment by Year
  • Figure 17 Chart of Product Base vs. Final
  • Figure 18 Chart of Base Year by Product
  • Figure 19 Chart of Final Year by Product
  • Figure 20 Chart of Growth by User
  • Figure 21 Chart of User Segment by Year
  • Figure 22 Chart of User Base vs. Final
  • Figure 23 Chart of Base Year by User
  • Figure 24 Chart of Final Year by User
  • Figure 25 Chart - Endocrine Segment vs Total Market Growth
  • Figure 26 Chart - Immune Growth vs. Total
  • Figure 27 Chart - Oncology vs Total
  • Figure 28 Chart - Infectious Disease Immunoassay vs Total
  • Figure 29 Chart - Cardiology Immunoassay vs total
  • Figure 30 Chart - Other Immunoassay vs Total
  • Figure 31 Chart - Enzyme Segment vs Total Market Growth
  • Figure 32 Chart - Flourescence Growth vs. Total
  • Figure 33 Chart - Chemiluminescence vs Total
  • Figure 34 Chart - Nucleic Acid Immunoassay vs Total
  • Figure 35 Chart - Rapid/POC Immunoassay vs total
  • Figure 36 Chart - Other Technology Immunoassay vs Total
  • Figure 37 Chart - Instrument Segment vs Total Market Growth
  • Figure 38 Chart - Reagents Growth vs. Total
  • Figure 39 Chart - Services vs Total
  • Figure 40 Chart - Hospital Segment vs Total Market Growth
  • Figure 41 Chart - Outpatient Lab Growth vs. Total
  • Figure 42 Chart - POC/Other vs Total
目次

OVERVIEW:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 60 companies, large and small, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Immunoassay Market - Strategic Situation Analysis
  • 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

  • 2.1 Immunoassay Markets Definition In This Report
    • 2.1.1 Enzyme Based
    • 2.1.2 Immunofluorescence
    • 2.1.3 Chemiluminescence
    • 2.1.4 DNA/NAT
    • 2.1.5 RIA & Other
    • 2.1.6 Reagents/Kits, Analyzers, Software & Services
    • 2.1.7 Infectious Disease
    • 2.1.8 Auto Immune
    • 2.1.9 Endocrinology
    • 2.1.10 Oncology
    • 2.1.11 Cardiology
    • 2.1.12 Other Specialty
  • 2.2 Market Definition
    • 2.2.1 Market Sizes
    • 2.2.2 Currency
    • 2.2.3 Years
  • 2.3 Methodology
    • 2.3.1 Methodology
    • 2.3.2 Sources
    • 2.3.3 Authors
  • 2.4 Perspective: Healthcare and the IVD Industry
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 The Clinical Laboratory Market Segments
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
    • 3.2.3 Hospital Testing Share
    • 3.2.4 Economies of Scale
    • 3.2.5 Hospital vs. Central Lab
    • 3.2.6 Physician Office Lab's
    • 3.2.7 Physician's and POCT
  • 3.3 Immunoassay -Markets and Discussion
    • 3.3.1 Instruments - Genetics changes the picture
      • 3.3.1.1 RIA - A Technology Shows its Age
      • 3.3.1.2 Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
      • 3.3.1.3 The Smart Shrinking Instrument - Serious Implications
      • 3.3.1.4 Research Funding and Capital Expense - Instrument Pooling
      • 3.3.1.5 Multiplex vs. POC - A Tradeoff Analysis
    • 3.3.2 Reagents and Kits - Genetics changes the picture
      • 3.3.2.1 Bigger Test Menus a Boon for Kit Market
      • 3.3.2.2 Physician Office Labs - A New Frontier
    • 3.3.3 Rapid and POCT to Threaten Instrument Markets
    • 3.3.4 OTC and DTC - Huge Market Potential
    • 3.3.5 Economies of Scale. Going Away?
    • 3.3.6 Lower Barriers to Entry for Instruments/Analyzers
    • 3.3.7 Miniturization and Technology Drive Acquisition

4 Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Diagnostic Factors
    • 4.1.2 Changing Technologies Spur Early Instrument Retirement
    • 4.1.3 Consumer Channels Open Wider
    • 4.1.4 Immunity Technology Comes of Age
  • 4.2 Factors Limiting Growth
    • 4.2.1 Increased Competition Lowers Price
    • 4.2.2 Threat from PCR Based Instruments
    • 4.2.3 Lower Barriers to Entry
    • 4.2.4 Wellness has a downside
  • 4.3 Immunoassay Instrumentation
    • 4.3.1 Instrumentation Tenacity
    • 4.3.2 Declining Cost of Instruments Changes Industry Structure
    • 4.3.3 LISTING of INSTRUMENT SPECIFICATIONS
    • 4.3.4 Immunoassay - CRISPR Diagnostics

5 Immunoassay Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
  • 5.2 EDP Biotech, New Day Diagnostics to Merge
  • 5.3 Sorrento Therapeutics Nabs Contract for Dx Platform
  • 5.4 Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
  • 5.5 Qorvo Eyes Multiplex Immunoassay
  • 5.6 BioMérieux Launches New Products
  • 5.7 Senzo to Commercialize Infectious Disease Lateral Flow Tests
  • 5.8 Nanomix Plans Instrument, Test Launches
  • 5.9 Startup GLX Analytix Prepares for Commercialization
  • 5.10 Nonagen Gets CE Mark for Bladder Cancer Immunoassay
  • 5.11 Qualigen Acquires Majority Stake in NanoSynex
  • 5.12 Saladax Biomedical Using Immunoassay Dx
  • 5.13 Prolight Diagnostics to Acquire Psyros Diagnostics
  • 5.14 Quidel to Acquire Ortho Clinical Diagnostics
  • 5.15 FDA Grants EUA to Xtrava Health
  • 5.16 Alamar Biosciences Develops Immuno-Sandwich Platform
  • 5.17 FDA grants breakthrough device to multiplex immunoassay
  • 5.18 Quidel, Beckman Settle Cardiac Immunoassay Dispute
  • 5.19 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership
  • 5.20 BioMérieux Gets CE Mark for Three Dengue Immunoassays
  • 5.21 COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing
  • 5.22 Roche Diagnostics Expanding Testing Portfolio in 2021
  • 5.23 PerkinElmer Long-Term Outlook
  • 5.24 Quidel Updates Outlook for C19 Testing
  • 5.25 Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza
  • 5.26 Becton Dickinson and NAT Diagnostics Acquisition

6 Profiles of Key Companies

  • 6.1 Abbott Laboratories
  • 6.2 Abcam
  • 6.3 Abionic
  • 6.4 Accel Diagnostics
  • 6.5 Applied BioCode
  • 6.6 Arlington Scientific
  • 6.7 Arrayit Corporation
  • 6.8 Atomo Diagnostics
  • 6.9 Aureum Diagnostics
  • 6.10 Aurora Biomed
  • 6.11 Autobio Diagnostics
  • 6.12 AVIVA Systems Biology
  • 6.13 Awareness Technology
  • 6.14 Axis-Shield Diagnostics Ltd.
  • 6.15 Beckman Coulter Diagnostics
  • 6.16 Becton, Dickinson and Company
  • 6.17 Biocartis
  • 6.18 Biomatik
  • 6.19 bioMérieux Diagnostics
  • 6.20 Bioneer Corporation
  • 6.21 Bio-Rad Laboratories, Inc.
  • 6.22 BioTek Instruments
  • 6.23 Boditech Med, Inc
  • 6.24 Boster Biological Technology
  • 6.25 Diamedix (Erba Diagnostics)
  • 6.26 Diasorin S.p.A.
  • 6.27 Dynex Technologies
  • 6.28 Enzo Biochem
  • 6.29 Eurofins Scientific
  • 6.30 FUJIFILM Wako Diagnostics
  • 6.31 Fujirebio
  • 6.32 Gold Standard Diagnostics
  • 6.33 Grifols
  • 6.34 Hycor Biomedical
  • 6.35 Immunodiagnostic Systems (IDS)
  • 6.36 Immunodiagnostik AG
  • 6.37 Inova Diagnostics
  • 6.38 JR Biomedical
  • 6.39 Luminex Corp
  • 6.40 Maxim Biomedical
  • 6.41 Mbio Diagnostics
  • 6.42 Meso Scale Discovery
  • 6.43 Millipore Sigma
  • 6.44 Mindray
  • 6.45 Molecular Devices
  • 6.46 MP Biomedical
  • 6.47 Operon
  • 6.48 Ortho Clinical Diagnostics
  • 6.49 Perkin Elmer
  • 6.50 Qiagen
  • 6.51 Quidel
  • 6.52 R&D Systems
  • 6.53 Randox Toxicology
  • 6.54 Roche Molecular Diagnostics
  • 6.55 SD Biosensor
  • 6.56 Siemens Healthineers
  • 6.57 Sysmex
  • 6.58 Tecan
  • 6.59 Thermo Fisher Scientific Inc.
  • 6.60 TOSOH Bioscience
  • 6.61 Veredus Laboratories
  • 6.62 Vircell
  • 6.63 YD Diagnostics
  • 6.64 Zhejiang Orient Gene Biotech

7 The Global Market

  • 7.1 Global Market by Country
    • 7.1.1 Global Market by Country Table
    • 7.1.2 Global Market by Country Chart
  • 7.2 Global Market by Application
    • 7.2.1 Global Market by Application Table
    • 7.2.2 Global Market by Application Segment Growth Chart
    • 7.2.3 Global Market by Application Segment Annual Chart
    • 7.2.4 Global Market by Application Segment Base vs. Final
    • 7.2.5 Global Market by Application Base Year
    • 7.2.6 Global Market by Application Final Year
  • 7.3 Global Market by Technology
    • 7.3.1 Global Market by Technology Table
    • 7.3.2 Global Market by Technology Segment Growth Chart
    • 7.3.3 Global Market by Technology Segment Annual Chart
    • 7.3.4 Global Market by Technology Segment Base vs. Final
    • 7.3.5 Global Market by Technology Base Year
    • 7.3.6 Global Market by Technology Final Year
  • 7.4 Global Market by Product
    • 7.4.1 Global Market by Product Table
    • 7.4.2 Global Market by Product Segment Growth Chart
    • 7.4.3 Global Market by Product Segment Annual Chart
    • 7.4.4 Global Market by Product Segment Base vs. Final
    • 7.4.5 Global Market by Product Base Year
    • 7.4.6 Global Market by Product Final Year
  • 7.5 Global Market by User
    • 7.5.1 Global Market by User Table
    • 7.5.2 Global Market by User Segment Growth Chart
    • 7.5.3 Global Market by User Segment Annual Chart
    • 7.5.4 Global Market by User Segment Base vs. Final
    • 7.5.5 Global Market by User Base Year
    • 7.5.6 Global Market by Application Final Year

8 Global Market by Application

  • 8.1 Endocrinology Applications
    • 8.1.1 Endocrinology Applications by Country Table
    • 8.1.2 Endocrinology Applications Growth Chart
  • 8.2 Immune Applications
    • 8.2.1 Immune Applications by Country Table
    • 8.2.2 Immune Applications Growth Chart
  • 8.3 Oncology Applications
    • 8.3.1 Oncology Applications by Country Table
    • 8.3.2 Oncology Applications Growth Chart
  • 8.4 Infectious Disease Applications
    • 8.4.1 Infectious Disease Applications by Country Table
    • 8.4.2 Infectious Disease Applications Growth Chart
  • 8.5 Cardiology Applications
    • 8.5.1 Cardiology Applications by Country Table
    • 8.5.2 Cardiology Applications Growth Chart
  • 8.6 Other Applications
    • 8.6.1 Other Applications by Country Table
    • 8.6.2 Other Applications Growth Chart

9 Immunoassay by Technology

  • 9.1 Enzyme
    • 9.1.1 Enzyme by Country Table
    • 9.1.2 Enzyme Growth Chart
  • 9.2 Flourescence
    • 9.2.1 Flourescence by Country Table
    • 9.2.2 Flourescence Growth Chart
  • 9.3 Chemiluminescence
    • 9.3.1 Chemiluminescence by Country Table
    • 9.3.2 Chemiluminescence Growth Chart
  • 9.4 Nucleic Acid
    • 9.4.1 Nucleic Acid by Country Table
    • 9.4.2 Nucleic Acid Growth Chart
  • 9.5 Rapid/POC
    • 9.5.1 Rapid/POC by Country Table
    • 9.5.2 Rapid/POC Growth Chart
  • 9.6 Other Technology
    • 9.6.1 Other Technology by Country Table
    • 9.6.2 Other Technology Growth Chart

10 Immunoassay by Product

  • 10.1 Instrument
    • 10.1.1 Instrument by Country Table
    • 10.1.2 Instrument Growth Chart
  • 10.2 Reagents
    • 10.2.1 Reagents by Country Table
    • 10.2.2 Reagents Growth Chart
  • 10.3 Services
    • 10.3.1 Services by Country Table
    • 10.3.2 Services Growth Chart

11 Immunoassay by User

  • 11.1 Hospital
    • 11.1.1 Hospital by Country Table
    • 11.1.2 Hospital Growth Chart
  • 11.2 Outpatient Lab
    • 11.2.1 Outpatient Lab by Country Table
    • 11.2.2 Outpatient Lab Growth Chart
  • 11.3 POC/Other
    • 11.3.1 POC/Other by Country Table
    • 11.3.2 POC/Other Growth Chart

12 Vision of the Future of Immunoassay

13 Appendices

  • 13.1 United States Medicare System: Laboratory Fees Schedule
  • 13.2 The Most Used IVD Assays
  • 13.3 The Highest Grossing Assays